CPC Biotech Debuts Unified Bioprocess Fluid Portfolio
CPC Biotech, a new brand under Dover’s Pump Solutions Group, launched by merging CPC’s sterile connector expertise with PSG Biotech’s low‑shear pumps, flow meters and sensors. The unified portfolio offers biopharma manufacturers a single source for connectors, pumps, and measurement devices across the entire fluid path. The company will debut the full line at INTERPHEX 2026 in New York, showcasing its integrated solutions to the cell and gene therapy markets. Global manufacturing spans North America, Europe and Asia, supporting customers in more than 50 countries.
Smoking Ban for People Born After 2008 in the UK Agreed
The UK Parliament has approved the Tobacco and Vapes Bill, which will ban anyone born after 1 January 2009 from ever purchasing cigarettes, creating a legally enforced smoke‑free generation. The legislation also grants ministers new authority over tobacco, vaping and nicotine product...
Why It Pays to Play the Long Game on Advanced Primary Care
Employer‑sponsored insurance plans are seeing urgent‑care spending jump more than 50% between 2018 and 2022, signaling a shift toward fragmented, quick‑care services. In response, many employers are adopting advanced primary care models that emphasize prevention, chronic‑disease management, and sustained patient‑provider...
AI Could Help NHS Clinicians Diagnose Childhood Sleep Apnoea, Study Finds
Seluna, a Glasgow‑based health‑tech firm, piloted its cloud‑based AI autoscoring software on 500 retrospective paediatric sleep studies from NHS Greater Glasgow and Clyde. The algorithm flagged severe sleep apnoea with 100% accuracy, while mild and moderate cases were identified with...
How the Right Living Environment Transforms Outcomes for People With Disability
The article highlights how supported independent living and tailored disability accommodation improve health outcomes for people with disabilities. It explains the shift from institutional settings to community‑based homes, driven by Australia’s National Disability Insurance Scheme (NDIS) which funds housing and...
Atsena Secures DMC Approval for LIGHTHOUSE Trial
Atsena Therapeutics received a recommendation from its independent data monitoring committee to launch the pivotal Part C of the LIGHTHOUSE Phase I/II/III trial for ATSN‑201, its gene‑therapy candidate targeting X‑linked retinoschisis (XLRS). Part C will enroll 76 patients across Europe and North America,...
Continuous AI Biometric Identification: Why Manual Patient Verification Is Not Enough!
Patient misidentification remains a pervasive safety and cost issue in U.S. healthcare, with up to 12% of electronic health records duplicated and clinicians reporting frequent errors. Traditional wristband and verbal checks are prone to human error, prompting a shift toward...
Oracle Cerner: Potential Acquirers of Oracle Health
Oracle is weighing a divestiture of its Cerner acquisition, now branded Oracle Health, to free cash for a $50 billion AI‑infrastructure spend and to service a $124 billion debt load. The $28.3 bn health‑tech asset has seen customer churn, with 57 acute‑care systems...
Key Considerations in Healthcare Litigation Cases Today
The article outlines essential considerations for healthcare litigation, emphasizing patient rights, thorough medical documentation, and strict regulatory compliance. It highlights the pivotal role of expert testimony, insurance knowledge, and confidentiality safeguards in shaping case outcomes. The piece contrasts settlement advantages...
States and Territories Left in the Dark on NDIS Savings
Australia’s federal government is set to unveil a new package of NDIS reforms aimed at slowing the scheme’s cost growth from about 9.5% to 5‑6% per year, a move projected to save roughly $4 billion AUD ($2.6 bn USD) annually over the...
AstraZeneca’s Ultomiris Cuts Urine Protein in Late-Stage Kidney Disease Trial
AstraZeneca announced that its rare‑blood‑disorder drug Ultomiris achieved the primary goal in a late‑stage trial for IgA nephropathy, a rare kidney disease. An interim analysis showed a statistically significant reduction in urine protein by week 34, with effects detectable as early...
Probiotics Shown to Relieve Constipation in Kids: Vietnam RCT
A Vietnam‑based randomized, double‑blind trial found that two Bacillus spore probiotic liquids, LiveSpo Kids and LiveSpo Preg‑Mom, significantly eased functional constipation in preschool children. Over four weeks, the probiotic groups experienced a 3.6‑ to 4‑fold reduction in low‑frequency bowel movements,...
Hello Inside Pushes Metabolic Health Into Mainstream Care with BARMER Deal
Hello Inside, an Austrian startup, is bringing CGM‑based metabolic tracking to women’s health and has secured a partnership with BARMER, Germany’s statutory insurer covering over 9 million members, to offer the program for free. The platform combines glucose data with sleep,...
How Motor Architecture Shapes Surgical Hand Tool Performance
Portescap’s new white paper highlights motor architecture as a pivotal early‑stage decision for surgical hand‑tool design. It breaks down four core architectures—slotted, slotless, brushless DC and core‑less brushed—showing how each influences torque density, vibration, speed range and thermal management. The...
Maternity Boss 'Confident' As Unit Reopens
The Somerset NHS Foundation Trust has reopened the maternity services and Special Care Baby Unit at Yeovil District Hospital, which were shut in May 2025 after the Care Quality Commission flagged staffing, equipment and incident‑learning deficiencies. The trust recruited additional...
AI Companions Developed for Lonely Students in Australia
Researchers at the University of New South Wales have built two prototype AI companions, Tom and Mia, to help university students cope with loneliness. The chatbots, designed in English and Mandarin, were co‑created with Chinese student input and incorporate safeguards...
Muscle Energy Recovery May Explain Fatigue in Cancer Survivors
A pilot study using phosphorus‑31 magnetic resonance spectroscopy (31P‑MRS) measured how quickly skeletal‑muscle mitochondria restore energy after exertion in 11 cancer survivors. Older participants (≥65) recovered about 10% slower and showed weaker grip strength, higher self‑reported fatigue, and fewer daily...
Tourists More Likely to Undergo Unnecessary Imaging in the ED
A new study of 740,000 emergency department visits in Italy’s Trentino province (2018‑2024) shows tourists—who made up about 18% of patients—accounted for roughly 20% of all radiologic exams. Tourists faced a 32% higher odds of receiving excess imaging, with red‑triage...
Policy Expert Believes CMS Is Taking “Adversial Posture” To Medicare Advantage
At the Medicarians conference, policy analyst Tom Kornfield warned that CMS is taking an increasingly adversarial stance toward Medicare Advantage (MA) amid concerns about overpayments, fraud and political scrutiny. The agency cites $76 billion in excess payments and recent data‑validation audits,...
What Is Dry Needling? And Does It Work?
Dry needling, an ultrathin‑needle technique targeting muscle trigger points, entered mainstream physical‑therapy after the AMA endorsed it in 2016. The method has been embraced by high‑profile athletes such as Travis Kelce and Caitlin Clark, positioning it as a fast‑acting recovery tool. However,...
APC-Deficient Cancer Cells Rely on Single Enzyme for Survival
Researchers have identified aldehyde dehydrogenase 2 (ALDH2) as a critical survival factor for colorectal cancer cells lacking functional APC. Computational screening and lab experiments show that pharmacological inhibition of ALDH2, using agents such as disulfiram, sharply reduces proliferation and induces...
Trial Shows Safety of Novel KIR-CAR T Therapy in Solid Tumors
A Phase I dose‑escalation trial of SynKIR‑110, a novel KIR‑CAR T therapy, demonstrated safety in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma. The multi‑chain design uses NK‑cell receptors to provide an on/off switch, reducing T‑cell exhaustion and side...
WHO-Recommended Antibiotics Ineffective for Many Neonatal Sepsis Cases
Researchers from Oxford and a network of hospitals in Pakistan, Bangladesh and Nigeria presented the BARNARDS II study at ESCMID Global 2026, revealing that the WHO‑recommended first‑line antibiotics ampicillin plus gentamicin are likely effective against only 25 % of neonatal sepsis pathogens in...
Hospital System Pours $20M Into Expanding Imaging, Oncology Services
Rochester Regional Health, a New York health system, announced a $20 million investment to expand its oncology and imaging services. An $8.9 million expansion at the Lipson Cancer Institute will double infusion bays from 10 to 20 and add a dedicated oncology pharmacy....
CRISPR Screens Map Human T‑Cell Genes That Promote or Block HIV Infection
Researchers at Gladstone Institutes and UCSF used genome‑wide CRISPR activation and knockout screens in primary human CD4+ T cells to map host genes that either promote or restrict HIV infection. By optimizing infection rates to about 70%, they could perturb...
Trump’s Psychedelic Order Tests Review Norms
BioCentury’s website uses a tiered cookie system to support essential functions, personalization, marketing, advertising, and analytics. Strictly necessary cookies are always active, enabling authentication, registration, and navigation, while functional cookies enhance site features. Marketing and advertising cookies help tailor product...
Morning Brief Podcast: India's Medical Tourism Slips Off the Table
India’s medical tourism sector is experiencing a quiet decline, with foreign patient arrivals dropping about a third since 2019—from roughly 700,000 to 500,000. The slowdown is driven by strained Bangladesh ties, visa processing delays of up to 60 days, and...
Nektar’s Phase II Alopecia Extension Reveals Late Responders to IL-2 Therapy
Nektar Therapeutics reported results from a Phase II extension study of its interleukin‑2 (IL‑2) therapy for alopecia areata. The data revealed a subset of patients who did not respond initially but achieved meaningful hair regrowth after prolonged exposure, raising the...
Quest Diagnostics Inc (DGX) Q1 2026 Earnings Call Transcript
Quest Diagnostics reported Q1 2026 revenue of $2.81 billion, a 7.1% year‑over‑year increase, driven by strong physician, hospital and consumer channels. Advanced diagnostics and the questhealth.com platform delivered double‑digit growth, with the consumer platform reaching a $100 million run rate. Strategic collaborations,...
Personalized CRISPR Therapies Could Soon Reach Thousands — Here’s How
The FDA has proposed a "plausible mechanism" pathway to streamline approval of personalized CRISPR gene‑editing therapies. The new framework would let developers test multiple patient‑specific guide RNAs within a single trial, potentially shrinking the approval timeline from four years to...
Vaccines Mean Malaria Deaths Should Be Falling — Not Rising
Global malaria cases climbed to 282 million and deaths to 610 k in 2024, reversing earlier gains. The WHO‑endorsed vaccines RTS,S and R21 are in use in only 25 countries, leaving high‑risk African nations such as Tanzania without protection. Funding gaps are...
Re-Evaluating the Effectiveness of Ultrabrief Pulse ECT: The Potential Role of (In)appropriate Seizure Threshold Titration
In a recent correspondence, Meijer et al. challenge a new meta‑analysis that found ultrabrief pulse (UBP) electroconvulsive therapy (ECT) less effective than brief pulse (BP) ECT for depression. They propose that many UBP studies used inappropriate seizure‑threshold titration, delivering higher‑than‑intended stimulus...
Community Health Systems Inc (CYH) Q1 2026 Earnings Call Transcript
Community Health Systems posted a 6.5% year‑over‑year increase in same‑store net revenue, driven by rate hikes and new state‑directed payment (SDP) program revenue in New Mexico and Tennessee. Adjusted EBITDA slipped to $380 million, prompting a narrowed full‑year guidance of $1.45‑$1.55 billion....
UnitedHealth Group Inc (UNH) Q1 2026 Earnings Call Transcript
UnitedHealth Group reported Q1 2026 adjusted earnings of $2.92 per share and revenue of over $113 billion, a 12% year‑over‑year increase driven by 780,000 new domestic lives. Medical care and operating cost ratios rose, reflecting higher claim costs and technology investments,...
US Speeds Research Into Mind-Altering Drugs — Including Mysterious 'Ibogaine'
On April 18, President Donald Trump signed an executive order to accelerate U.S. research on ibogaine and other psychedelics, directing the FDA to fast‑track review and providing $50 million in federal funding to match state programs. The order aims to ease...
Single-Cell Epigenomes Link Fat to Heart Disease Risk
A new study leveraging single‑cell epigenomic profiling of human adipose tissue has uncovered distinct regulatory signatures that link excess fat to heightened heart disease risk. Analyzing over 200,000 fat cells from 500 donors, researchers identified 12 epigenetic regions that correlate...
Morning Headlines 4/21/26
The piece reflects growing unease about technology’s pervasive impact on learning, arguing that its harms are not limited to youth and should be addressed with age‑neutral policies. It highlights a semantic debate between "digitize" (converting analog content) and "digitalize" (re‑engineering...
New Federal Focus on Fraud, Waste and Abuse May Signal Changes for the Health Care Industry
The Trump Administration and Congress have intensified a federal campaign against health‑care fraud, waste, and abuse, launching an interagency task force and expanding criminal prosecutions. CMS imposed a six‑month moratorium on DMEPOS supplier enrollment and deferred $259.5 million in Medicaid matching...
Marshall: Behavioral Health Providers Should Use One EMR, Dashboard
Sen. Roger Marshall (R‑KS) is urging Congress to mandate that all behavioral health providers adopt a single electronic medical record (EMR) system and a unified mental‑health dashboard. The proposal would tie compliance to federal funding, imposing penalties on providers that...
Smartphone Video Enhances Parkinson’s DBS Programming
Researchers have introduced StimVision, a smartphone‑based system that records video of Parkinson’s patients performing motor tasks and converts the footage into quantitative kinematic data for deep brain stimulation (DBS) programming. The platform’s computer‑vision and machine‑learning algorithms generate metrics that align...
Lab-Grown Mini Brain Models Offer New Hope for Diagnosing and Treating Alzheimer’s Disease
Johns Hopkins researchers created patient‑derived hindbrain organoids that faithfully reproduce Alzheimer’s molecular hallmarks. Using these mini‑brains, they tested the SSRI escitalopram, uncovering strikingly different serotonin‑signaling responses across individual organoids. Proteomic analysis of extracellular vesicles revealed disease‑related proteins that shifted with...
Lifting Weights Builds a Sharper Mind and Reduces Anxiety in Older Women
A three‑month randomized trial found that older women who engaged in resistance training—whether using heavier weights for eight to twelve reps or lighter weights for ten to fifteen reps—experienced significant gains in cognitive performance and marked reductions in depression and...
NCQA and West Health Collaborate to Enhance Integration of Behavioral Health Within Primary Care Systems
The National Committee for Quality Assurance (NCQA) and West Health have formed a strategic partnership to develop standardized quality measures that embed behavioral health into primary‑care settings. By combining NCQA’s measurement expertise with West Health’s Accelerator model, the alliance will...
STAT+: At AACR, a Provocative Use of CAR-T, Merck’s New Thing and Cancer’s Geography Problem
At the AACR 2026 meeting, early‑phase data showed Merck‑partnered CAR‑T therapy Carvykti eliciting deep responses in 20 high‑risk smoldering multiple myeloma patients, suggesting a preventive angle for a precursor disease. The conference also featured Merck’s first glimpse of an oncology...
Out-of-Network Pricing Lawsuits Test MultiPlan, Zelis Business Models
Healthcare providers have filed antitrust lawsuits alleging that insurers and pricing intermediaries Zelis and MultiPlan conspired to suppress out‑of‑network payments using proprietary repricing algorithms. The Zelis case survived a motion to dismiss, with a judge finding plausible price‑fixing claims, while...
On-Site ‘Dialysis Dens’ at Nursing Homes Boost Care Continuity, a Boon for VBC and Hospital Partnerships
On‑site dialysis “dens” are being introduced in nursing homes, with Eduro Healthcare piloting the model at one of its 40 facilities through a partnership with Rendevor Dialysis. The on‑site setup eliminates transport‑related delays, improves care coordination, and gives residents additional...
Baltimore to Use $1M in Grant Funding for 911 Diversion Program
Baltimore will use a $1.03 million federal grant to broaden its 911 diversion program, extending services beyond behavioral‑health emergencies to a wider range of non‑violent calls. The funding, secured by Rep. Kweisi Mfume, builds on a program launched in 2021 under a...
Trump Clears Path for Expanded Psychedelic Research to Treat Veterans’ PTSD
President Donald Trump signed an executive order directing the FDA to accelerate reviews of psychedelic therapies and earmarking at least $50 million for ibogaine research aimed at treating veteran PTSD. The order also creates a Right‑to‑Try pathway for severely ill patients...
Delgocitinib Maintains QOL, Productivity Improvements at 52 Weeks in Chronic Hand Eczema
The open‑label DELTA 3 extension of the phase 3 delgocitinib trials shows that patients with moderate‑to‑severe chronic hand eczema who continued with twice‑daily or as‑needed delgocitinib cream for a full year maintained significant gains in disease‑specific and generic quality‑of‑life scores. Across 472...
How Trump's Psychedelics Executive Order Could Unlock Stalled Cannabis Reform
President Donald Trump signed an executive order that accelerates research, clinical trials, and Right‑to‑Try access for psychedelics such as psilocybin, MDMA and ibogaine, while leaving their scheduling unchanged. The order follows a prior, stalled effort to reschedule cannabis, highlighting the...